Clobazam 20 MG Oral Film [Sympazan] — RxCUI 2102715
RxNorm drug concept · Semantic branded drug
RxCUI 2102715
Semantic branded drug · SBD
● Current RxNorm concept 3 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2102715
Official nameClobazam 20 MG Oral Film [Sympazan]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSympazan 20 MG Oral Film
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)5,673 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Clobazam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Clobazam is an add-on medicine for seizures caused by Lennox-Gastaut syndrome in people 2 years and older. It is used along with other seizure medicines, not on its own.
- Take it by mouth exactly as prescribed, usually split into two doses a day if your dose is above the lowest amount. You can take it with or without food. Tablets can be swallowed w...
- No. Stopping suddenly can cause withdrawal reactions, including seizures, and can be life-threatening. Your prescriber will lower the dose slowly over time.
- Sleepiness is the most common. You may also notice tiredness, fever, constipation, drooling, irritability, or poor balance. Call your doctor right away for a rash, breathing troubl...
🕸️ Concept Web — How Clobazam 20 MG Oral Film [Sympazan] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Clobazam 20 MG Oral Film [Sympazan]
RxCUI 2102715 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Clobazam
21241IN
-
Clobazam
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Sympazan
2102708BN
-
Sympazan
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Clobazam Oral Film
2269618SCDF -
Clobazam Oral Film Product
2269617SCDG -
Clobazam Oral Product
1163749SCDG -
Clobazam Oral Film [Sympazan]
2269620SBDF -
Sympazan Oral Film Product
2269621SBDG -
Sympazan Oral Product
2102711SBDG -
Oral Film
2269575DF -
Oral Film Product
2269502DFG - +1 more in this family
-
Clobazam Oral Film
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Clobazam 20 MG Oral Film
2058254SCD -
Clobazam 20 MG
332882SCDC -
Clobazam 20 MG [Sympazan]
2102714SBDC
-
Clobazam 20 MG Oral Film
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Clobazam 20 MG Oral Film
SCD · 2058254 -
Clobazam 20 MG
SCDC · 332882 -
Clobazam Oral Film
SCDF · 2269618 -
Clobazam Oral Film Product
SCDG · 2269617 -
Clobazam Oral Product
SCDG · 1163749
Brand-Name Concepts
-
Clobazam 20 MG [Sympazan]
SBDC · 2102714 -
Clobazam Oral Film [Sympazan]
SBDF · 2269620 -
Sympazan Oral Film Product
SBDG · 2269621 -
Sympazan Oral Product
SBDG · 2102711 -
Sympazan
BN · 2102708
📦 FDA Products & Package NDCs
3 products · 3 package NDCs
3 package NDCs map to RxCUI 2102715 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 10094-0205-60 | 60 POUCH in 1 PACKAGE (10094-205-60) / 1 FILM in 1 POUCH (1... | SYMPAZAN | Aquestive Therapeutics | 2018-11-01 |
| 10094-0210-60 | 60 POUCH in 1 PACKAGE (10094-210-60) / 1 FILM in 1 POUCH (1... | SYMPAZAN | Aquestive Therapeutics | 2018-11-01 |
| 10094-0220-60 | 60 POUCH in 1 PACKAGE (10094-220-60) / 1 FILM in 1 POUCH (1... | SYMPAZAN | Aquestive Therapeutics | 2018-11-01 |
Observed labelers:
Aquestive Therapeutics (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.